Critical care and COVID-19: Dr. Matt Aldrich
Matt Aldrich, MD, medical director of critical care at UCSF Health in San Francisco, speaks about critical care issues in COVID-19.
Treatment options for COVID-19: Dr. Annie Luetkemeyer
Dr. Annie Luetkemeyer, professor of infectious diseases at UCSF, spoke with Dr. Robert Wachter, chair of the UCSF Department of Medcine, about the...
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?
Managing the COVID-19 isolation floor at UCSF Medical Center
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
Oral beta-lactams provide noninferior postdischarge pyelonephritis treatment
WASHINGTON – Beta-lactams were noninferior to fluoroquinolones or trimethoprim-...
Beta-blockers effective, safe for HFrEF with renal dysfunction
In PAD, dropping statins ups death risk 43%
PARIS – Statin adherence saves lives in peripheral arterial disease.
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug
Highlights from the ‘Updates in ACS’ session (VIDEO)